Cytek Biosciences, Inc.
Cytek Biosciences, Inc. (CTKB) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 408 transactions totaling $111.2M, demonstrating a bullish sentiment with $89.5M in net insider flow. The most recent transaction on Feb 18, 2026 involved a transaction of 1,346 shares valued at $0.
CTKB Insider Activity Summary
Who Is Buying CTKB Stock?
No significant insider buying has been recorded for CTKB in the recent period.
Who Is Selling CTKB Stock?
No significant insider selling has been recorded for CTKB in the recent period.
Is Cytek Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTKB is bullish with an Insider Alignment Score of 90/100 and a net flow of $89.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CTKB Frequently Asked Questions
Understanding CTKB Insider Activity
Insider trading at Cytek Biosciences, Inc. (CTKB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading CTKB stock, having executed 408 transactions in the past 90 days. The most active insider is Peter Kolchinsky (Executive), who has made 5 transactions totaling $50.1M.
Related Tools
Track Cytek Biosciences, Inc. Insider Activity
Get notified when executives and directors at CTKB file new Form 4 transactions